These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7163 related articles for article (PubMed ID: 10530563)
21. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738 [TBL] [Abstract][Full Text] [Related]
22. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors. Lau SK; Weiss LM; Chu PG Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271 [TBL] [Abstract][Full Text] [Related]
23. Establishment of three monoclonal antibodies specific for prespermatogonia and intratubular malignant germ cells in humans. Hiraoka N; Yamada T; Abe H; Hata J Lab Invest; 1997 Mar; 76(3):427-38. PubMed ID: 9121125 [TBL] [Abstract][Full Text] [Related]
24. Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors. Franke FE; Pauls K; Kerkman L; Steger K; Klonisch T; Metzger R; Alhenc-Gelas F; Burkhardt E; Bergmann M; Danilov SM Hum Pathol; 2000 Dec; 31(12):1466-76. PubMed ID: 11150371 [TBL] [Abstract][Full Text] [Related]
25. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding? Vogt AP; Chen Z; Osunkoya AO Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373 [TBL] [Abstract][Full Text] [Related]
26. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Takahashi K; Shichijo S; Noguchi M; Hirohata M; Itoh K Cancer Res; 1995 Aug; 55(16):3478-82. PubMed ID: 7627949 [TBL] [Abstract][Full Text] [Related]
27. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA; Neel HB; Strome SE; Roche P Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237 [TBL] [Abstract][Full Text] [Related]
28. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of p63 in testicular germ cell neoplasia. Emanuel PO; Unger PD; Burstein DE Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518 [TBL] [Abstract][Full Text] [Related]
30. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Marks A; Sutherland DR; Bailey D; Iglesias J; Law J; Lei M; Yeger H; Banerjee D; Baumal R Br J Cancer; 1999 May; 80(3-4):569-78. PubMed ID: 10408868 [TBL] [Abstract][Full Text] [Related]
31. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases. Miller JS; Lee TK; Epstein JI; Ulbright TM Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507 [TBL] [Abstract][Full Text] [Related]
32. Identification of two molecular groups of seminomas by using expression and tissue microarrays. Hofer MD; Browne TJ; He L; Skotheim RI; Lothe RA; Rubin MA Clin Cancer Res; 2005 Aug; 11(16):5722-9. PubMed ID: 16115909 [TBL] [Abstract][Full Text] [Related]
33. [Importance of determination of various histologic components in testicular germ cell tumors]. Kruslin B; Turcić M; Cupić H; Novosel I; Reljić A; Ruzić B; Belicza M Lijec Vjesn; 2003; 125(9-10):242-5. PubMed ID: 15038213 [TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815 [TBL] [Abstract][Full Text] [Related]
35. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. Bodey B; Siegel SE; Kaiser HE In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904 [TBL] [Abstract][Full Text] [Related]
36. Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study. Sugihara A; Saiki S; Tsuji M; Tsujimura T; Nakata Y; Kubota A; Kotake T; Terada N Anticancer Res; 1997; 17(5B):3861-5. PubMed ID: 9427793 [TBL] [Abstract][Full Text] [Related]
37. Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas. Chen YT; Cao D; Chiu R; Lee P Cancer Immun; 2013; 13():10. PubMed ID: 23885216 [TBL] [Abstract][Full Text] [Related]
38. Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminoma. Grobholz R; Verbeke CS; Schleger C; Köhrmann KU; Hein B; Wolf G; Bleyl U; Spagnoli GC; Coplan K; Kolb D; Iversen K; Jungbluth AA Urol Res; 2000 Dec; 28(6):398-403. PubMed ID: 11221919 [TBL] [Abstract][Full Text] [Related]
39. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases. Balzer BL; Ulbright TM Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328 [TBL] [Abstract][Full Text] [Related]
40. Molecular genetic changes in human male germ cell tumors. Lothe RA; Peltomäki P; Tommerup N; Fosså SD; Stenwig AE; Børresen AL; Nesland JM Lab Invest; 1995 Nov; 73(5):606-14. PubMed ID: 7474934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]